Xeris Biopharma Holdings (0A8E) Short Interest
LSE • 0A8E • US98422E1038
As of Oct 22, 2026, ORTEX estimated 0.1% of free float sold short, 25.8 days to cover, cost to borrow 0.36%. Sign up for live short interest data.
LSE • 0A8E • US98422E1038
As of Oct 22, 2026, ORTEX estimated 0.1% of free float sold short, 25.8 days to cover, cost to borrow 0.36%. Sign up for live short interest data.
This page tracks how heavily Xeris Biopharma Holdings (LSE:0A8E) is being shorted: ORTEX's daily short interest estimate, the cost to borrow the shares, utilization of the lendable supply and days to cover, next to the official exchange-reported figure.
Source: ORTEX. Some figures are limited on the free view; live data and full history are part of ORTEX Advanced.
Xeris Biopharma Holdings (LSE: 0A8E) has a market capitalization of $2.78B. Last close $14.58 (as of 2026-11-09); 52-week range $5.26 to $14.83. ORTEX data as of 2026-10-22: short interest was 0.09% of free float, 25.8 days to cover and the average cost to borrow was 0.36%. Sign up for live short interest data.